Evidence map›Paper›PMID 30276391›Full record

ArticleNanoscale2018

Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Maryam Hajfathalian, Ahmad Amirshaghaghi, Pratap C Naha, Peter Chhour, Jessica C Hsu, Keely Douglas, Yuxi Dong, Chandra M Sehgal, Andrew Tsourkas, Svetlana Neretina and 1 more

Abstract read
In one paragraph

Article in Nanoscale, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Nanomaterial-based contrast agents.Nature reviews. Methods primers · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Nanoparticle contrast agents for X-ray imaging applications.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Renally Excretable and Size-Tunable Silver Sulfide Nanoparticles for Dual-Energy Mammography or Computed Tomography.Chemistry of materials : a publication of the American Chemical Society · 2019
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maryam HajfathalianDepartment of Radiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. dcormode@upenn.edu.
Ahmad Amirshaghaghi
Pratap C Naha
Peter Chhour
Jessica C Hsu
Keely Douglas
Yuxi Dong
Chandra M Sehgal
Andrew Tsourkas
Svetlana Neretina
David P Cormode

Funding

Radiation and Receptor Targeted RadioTheranostic Nanoparticles for GlioblastomaR01CA181429 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DORSEY, JAY FITZGERALD · 2014 to 2018
$2.4M
Biodegradable polymetal nanoparticle CT contrast agents for vascular imagingR01HL131557 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CORMODE, DAVID PETER · 2016 to 2020
$2.0M
Integrated photoacoustic and ultrasound imaging with the Vevo LAZRS10OD016310 · OD · UNIVERSITY OF PENNSYLVANIA · PI SEHGAL, CHANDRA M · 2014 to 2014
$494k
NCI NIH HHS R01 CA181429NHLBI NIH HHS R01 HL131557NIH HHS S10 OD016310
6 · The paper itself

Abstract

Nanostructures have potential for use in biomedical applications such as sensing, imaging, therapeutics, and drug delivery. Among nanomaterials, gold nanostructures are of considerable interest for biomedical research, owing to their bio-inertness, controllable surface chemistry, X-ray opacity, and optical properties. Gold nanocages are particularly attractive for imaging and therapeutic applications, because they strongly absorb light in the near infra-red region which has high light transmission in tissue. However, the X-ray attenuation of nanocages is relatively low due to their hollow structure. In this study, for the first time, we sought to combine the attractive optical properties of nanoshells with the high payloads of solid nanoparticles and investigated their biomedical applications. Here, we report the engineering of Wulff in a cage nanoparticles via converting gold Wulff-shaped seeds into gold-silver core-shell structures and then performing a galvanic replacement reaction. The structure of these nanoparticles was determined using transition electron microscopy. This morphological transformation of gold nanoparticles shaped as truncated octahedrons into a complex Wulff in a cage nanoparticles during the reaction resulted in extensive changes in their optical properties that made these unique structures a potential contrast agent for photoacoustic imaging. We found that the Wulff in a cage nanoparticles had no adverse effects on the viabilities of J774A.1, Renca, and HepG2 cells at any of the concentrations tested. In vitro and in vivo experiments showed robust signals in both photoacoustic imaging and computed tomography. To the best of our knowledge, this is the first report of Wulff in a cage nanoparticles serving as a platform for multiple imaging modalities. This unique multifunctional nanostructure, which integrates the competencies of both core and shell structures, allows their use as contrast agents for photoacoustic imaging, computed tomography and as a potential agent for photothermal therapy.

Identifiers

PMID30276391
PMCPMC6190607

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.